Biochemotherapy With Temozolomide for Metastatic Melanoma
Status:
Terminated
Trial end date:
2010-04-01
Target enrollment:
Participant gender:
Summary
The goal of this clinical research study is to learn if treatment with Temodar
(temozolomide), Velban (vinblastine), Cisplatin, Proleukin (interleukin-2), Intron-A
(interferon alpha), and thalidomide can help to control melanoma that has spread to other
parts of the body. The safety of this treatment will also be studied.